trial

Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers

NCTId NCT04300946
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 48 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2025-10-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
48 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2021-10-10
Primary completion
2025-10-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
TMS targeted on the cerebellum

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Sites

1 total
Strasbourg, France

Facts & assertions

4 sourced
Enrollment
48
Phase
NA
Primary Completion Date
2025-10-01
Status
RECRUITING
relationships
The graph out of here
drug
TMS targeted on the cerebellum
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenia
indication
Schizophrenia
indication